Last reviewed · How we verify

NCT04113746

Asthma and Obesity: Pilot Study

Completed NA Results posted Last updated 14 November 2022
What this trial tests

NA trial testing Better asthma self-management and incorporation of physical activity in Asthma in 27 participants. Completed in 30 August 2021.

Timeline
3 October 2019
Primary endpoint
30 August 2021
30 August 2021

Quick facts

Lead sponsorIcahn School of Medicine at Mount Sinai
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment27
Start date3 October 2019
Primary completion30 August 2021
Estimated completion30 August 2021
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Icahn School of Medicine at Mount Sinai

Who can join

Adults 21 to 64, any sex, with Asthma or Obesity. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Beliefs About Illness Perception Questionnaire (BIPQ) Primary · At 30 days Post-pilot follow-up visit, up to 2 months

BIPQ includes 5 cognitive domains (Identity, Cause, Timeline, Consequences, and Cure-Control) designed to rapidly assess the cognitive and emotional representations of illness. Each item in each domain is scored on a 0 (none) to 10 (extreme). Full scale from 0-80, where higher score reflects a more threatening view of the illness.

GroupValue95% CI
Asthma and Exercise Lifestyle Change42.6± 11.4
Asthma Education36.2± 8.2
Medication Adherence Rating Scale (MARS) Secondary · At 30 days Post-pilot follow-up visit, up to 2 months

MARS is a self-reported questionnaire with the total score range from 0-10 with a higher score indicating better adherence.

GroupValue95% CI
Asthma and Exercise Lifestyle Change4.7± 0.5
Asthma Education4.7± 0.5
Physical Activity - Step Counts Per Day Secondary · Week 2, Week 4, and at 30 days Post-pilot follow-up visit

Physical activity monitoring using accelerometer and accompanying activity diary for self-report of wear. The accelerometer will measure step counts using previously determined cut-points. Based on accepted methodology, 3 or more out of the 7 days with 10 or more hours of wear time will be considered a valid measure of usual activity.

Week 2
GroupValue95% CI
Asthma and Exercise Lifestyle Change12253.3± 0
Asthma Education2499.7± 1514.9
Week 4
GroupValue95% CI
Asthma and Exercise Lifestyle Change13730.2± 0
Asthma Education2123.9± 1751.0
at 30 days post pilot follow-up visit
GroupValue95% CI
Asthma and Exercise Lifestyle Change2667.9± 375.4
Asthma Education3715.1± 3041.5
Time in Physical Activity Secondary · Week 2, Week 4, and at 30 days Post-pilot follow-up visit

Physical activity monitoring using accelerometer and accompanying activity diary for self-report of wear. The accelerometer measured time spent in different intensities of activity using previously determined cut-points. Based on accepted methodology, 3 or more out of the 7 days with 10 or more hours of wear time was considered a valid measure of usual activity.

Week 2
GroupValue95% CI
Asthma and Exercise Lifestyle Change74.5± 0
Asthma Education8.6± 7.0
Week 4
GroupValue95% CI
Asthma and Exercise Lifestyle Change91.5± 0
Asthma Education10.3± 8.3
at 30 days post pilot follow-up visit
GroupValue95% CI
Asthma and Exercise Lifestyle Change9.9± 6.8
Asthma Education7.8± 9.2
Asthma Control Questionnaire (ACQ) Secondary · at 30 days Post-pilot follow-up visit, up to 2 months

Asthma Control Questionnaire (ACQ) - self-reported asthma control validated survey, with a total score range from 0-6, with a higher score indicating severely uncontrolled asthma, used to assess current asthma control at 30 days post-pilot follow up visit.

GroupValue95% CI
Asthma and Exercise Lifestyle Change1.6± 1.0
Asthma Education1.3± 0.9
Asthma Quality of Life Questionnaire (AQLQ) Secondary · at 30 days post-pilot follow-up visit, up to 2 months

Asthma Quality of Life Questionnaire (AQLQ) - self-reported asthma-related quality of life validated survey used to assess asthma-related quality of life at 30 days post-pilot follow-up visit. Total Score from 1-7, with higher score indicating better quality of life.

GroupValue95% CI
Asthma and Exercise Lifestyle Change4.9± 0.8
Asthma Education5.0± 0.6
Beliefs About Medications Questionnaire (BMQ) - Necessity and Concerns Subscale Secondary · at 30 days post pilot follow-up visit, up to 2 months

Beliefs about Medications Questionnaire (BMQ) - Necessity and Concerns The BMQ comprises two separate two five-item sub-scales (Necessity and Concerns) and assesses respondents' beliefs about prescribed medicines that they are currently using for specific conditions, for e.g. asthma. It assesses patients' beliefs about the necessity of prescribed medication for controlling their disease and their concerns about potential adverse consequences of taking it. Respondents indicate their degree of agreement with each statement on a five-point Likert scale, ranging from 1 - strongly disagree to 5 -

Necessity Subscale
GroupValue95% CI
Asthma and Exercise Lifestyle Change15± 3.6
Asthma Education16.4± 5
Concerns Subscale
GroupValue95% CI
Asthma and Exercise Lifestyle Change8.4± 1
Asthma Education8.4± 2.7

Sponsor's own description

Develop and pilot test four theory-based educational modules that integrate counseling for asthma and obesity to promote greater physical activity among people with asthma.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Asthma

Currently open trials in the same condition.

Other Icahn School of Medicine at Mount Sinai trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04113746.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing